Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH
- PMID: 12060776
- PMCID: PMC123067
- DOI: 10.1073/pnas.102055799
Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH
Abstract
The pathogenesis of tuberculosis involves multiple phases and is believed to involve both a carefully deployed series of adaptive bacterial virulence factors and inappropriate host immune responses that lead to tissue damage. A defined Mycobacterium tuberculosis mutant strain lacking the sigH-encoded transcription factor showed a distinctive infection phenotype. In resistant C57BL/6 mice, the mutant achieved high bacterial counts in lung and spleen that persisted in tissues in a pattern identical to those of wild-type bacteria. Despite a high bacterial burden, the mutant produced a blunted, delayed pulmonary inflammatory response, and recruited fewer CD4(+) and CD8(+) T cells to the lung in the early stages of infection. In susceptible C3H mice, the mutant again showed diminished immunopathology and was nonlethal at over 170 days after intravenous infection, in contrast to isogenic wild-type bacilli, which killed with a median time to death of 52 days. Complete genomic microarray analysis revealed that M. tuberculosis sigH may mediate the transcription of at least 31 genes directly and that it modulates the expression of about 150 others; the SigH regulon governs thioredoxin recycling and may be involved in the maintenance of intrabacterial reducing capacity. These data show that the M. tuberculosis sigH gene is dispensable for bacterial growth and survival within the host, but is required for the production of immunopathology and lethality. This phenotype demonstrates that beyond an ability to grow and persist within the host, M. tuberculosis has distinct virulence mechanisms that elicit deleterious host responses and progressive pulmonary disease.
Figures
Similar articles
-
Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.Mol Microbiol. 2004 Apr;52(1):25-38. doi: 10.1111/j.1365-2958.2003.03958.x. Mol Microbiol. 2004. PMID: 15049808
-
The Mycobacterium tuberculosis SigD sigma factor controls the expression of ribosome-associated gene products in stationary phase and is required for full virulence.Cell Microbiol. 2005 Feb;7(2):233-44. doi: 10.1111/j.1462-5822.2004.00454.x. Cell Microbiol. 2005. PMID: 15659067
-
Characterization of the Mycobacterium tuberculosis sigma factor SigM by assessment of virulence and identification of SigM-dependent genes.Infect Immun. 2007 Jan;75(1):452-61. doi: 10.1128/IAI.01395-06. Epub 2006 Nov 6. Infect Immun. 2007. PMID: 17088352 Free PMC article.
-
Crosstalk between Mycobacterium tuberculosis and the host cell.Semin Immunol. 2014 Dec;26(6):486-96. doi: 10.1016/j.smim.2014.09.002. Epub 2014 Oct 7. Semin Immunol. 2014. PMID: 25303934 Free PMC article. Review.
-
Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection.Crit Rev Microbiol. 2017 Sep;43(5):621-630. doi: 10.1080/1040841X.2017.1283485. Epub 2017 Feb 17. Crit Rev Microbiol. 2017. PMID: 28338360 Review.
Cited by
-
The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes.PLoS One. 2012;7(1):e28958. doi: 10.1371/journal.pone.0028958. Epub 2012 Jan 3. PLoS One. 2012. PMID: 22235255 Free PMC article.
-
Aerosolized gentamicin reduces the burden of tuberculosis in a murine model.Antimicrob Agents Chemother. 2012 Feb;56(2):883-6. doi: 10.1128/AAC.05633-11. Epub 2011 Dec 5. Antimicrob Agents Chemother. 2012. PMID: 22143521 Free PMC article.
-
Redox homeostasis in mycobacteria: the key to tuberculosis control?Expert Rev Mol Med. 2011 Dec 16;13:e39. doi: 10.1017/S1462399411002079. Expert Rev Mol Med. 2011. PMID: 22172201 Free PMC article. Review.
-
Transcriptional characterization of the antioxidant response of Mycobacterium tuberculosis in vivo and during adaptation to hypoxia in vitro.Tuberculosis (Edinb). 2008 Jan;88(1):1-6. doi: 10.1016/j.tube.2007.08.007. Epub 2007 Oct 24. Tuberculosis (Edinb). 2008. PMID: 17928268 Free PMC article.
-
Natural transposon mutagenesis of clinical isolates of Mycobacterium tuberculosis: how many genes does a pathogen need?J Bacteriol. 2005 Oct;187(19):6726-32. doi: 10.1128/JB.187.19.6726-6732.2005. J Bacteriol. 2005. PMID: 16166535 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials